End Of Schultz Era Looms For Teva

CEO Kåre Schultz Unlikely To Renew Contract Past November 2023, Company Confirms

 
• By David Wallace
Kare Schultz
Kåre Schultz has been president and CEO of Teva since late 2017 • Source: Teva

More from Leadership

More from Generics Bulletin